Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XVIE in Androgenetic Alopecia
NCT07482423Phase 2Not yet recruiting
- Sponsor
- Restoration Biologics
- Start
- Dec 2026
- Primary completion
- May 2028
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of XVIE in androgenetic alopecia (AGA), sponsored by Restoration Biologics. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
XVIE
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT07482423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07482423.